A detailed history of Global Retirement Partners, LLC transactions in Argenx Se stock. As of the latest transaction made, Global Retirement Partners, LLC holds 29 shares of ARGX stock, worth $15,542. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29
Previous 13 123.08%
Holding current value
$15,542
Previous $5,000 140.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$356.01 - $451.55 $5,696 - $7,224
16 Added 123.08%
29 $12,000
Q1 2024

Apr 23, 2024

BUY
$356.95 - $413.29 $2,498 - $2,893
7 Added 116.67%
13 $5,000
Q4 2023

Jan 18, 2024

BUY
$338.91 - $506.01 $338 - $506
1 Added 20.0%
6 $2,000
Q3 2023

Oct 13, 2023

BUY
$369.35 - $548.43 $1,477 - $2,193
4 Added 400.0%
5 $2,000
Q1 2023

May 05, 2023

SELL
$334.23 - $403.65 $334 - $403
-1 Reduced 50.0%
1 $0
Q3 2022

Nov 03, 2022

BUY
$343.2 - $395.75 $686 - $791
2 New
2 $1,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $29.7B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.